Library Subscription: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Published 6 issues per year

ISSN Print: 0743-4863

ISSN Online: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Review Article: Fabricated Microparticles: An Innovative Method to Minimize the Side Effects of NSAIDs in Arthritis

Volume 33, Issue 5, 2016, pp. 433-488
DOI: 10.1615/CritRevTherDrugCarrierSyst.2016016624
Get accessGet access

ABSTRACT

Microparticles are polymeric bodies ranging 1−1000 µm that constitute a variety of forms such as microcapsules, microspheres, microcages, microshells, microrods, biosensors microparticles, radiolabeled microparticles, and so forth. This review focuses on general microparticles, mainly microcapsules and microspheres. Nonsteriodal anti-inflammatory drugs (NSAIDs) are one of the mostcommonly prescribed medications in the world. Most of the NSAIDs available have severe side effects. With increased awareness of NSAID-induced gastrointestinal (GI) side effects, safety has become a priority in treatment of arthritis and other inflammatory diseases with NSAIDs. A trend in NSAID development has been to improve therapeutic efficacy while reducing the severity of GI side effects by altering dosage through modified release to optimize drug delivery. One such approach is the use of fabricated microparticles such as microcapsules and microspheres as carriers of drugs. Microparticles provide delivery of macromolecules and micromolecules via different routes and effectively control the release profile of such drugs. Microcapsules and microspheres are compatible with most natural and synthetic polymers and can be used for several routes of administration, including parenteral, oral, nasal, intra-ocular, topical, and the like. Because of greater stability and multiple manufacturing techniques, microspheres and microcapsules are preferred as drug carriers over other colloidal drug delivery systems. Microparticles provide effective protection of the encapsulated agent against degradation by enzymatic activities, controlled and confined delivery of drugs from a few hours to months, and ingenious administration compared to alternative forms of controlled-release parenteral dosages, such as macro-sized implants. This comprehensive overview of fabricated microparticles describes microencapsulation technologies to produce microparticles for targeted therapy of arthritis and other inflammatory diseases which provide constant and prolonged therapeutic effects that reduce dosing frequency and thereby minimize potential adverse effects of NSAIDs such as GI irritation and insufficient patient compliance. The present review describes the latest developments in microparticulate drug delivery systems and the best alternatives for safe and effective microcapsular systems in a controlled manner for the delivery of NSAIDs.

CITED BY
  1. Abadi Shaivad Shabee Hulhasan, Gangadharappa H. V., Balamuralidhara V., Development of colon-specific mucoadhesive meloxicam microspheres for the treatment of CFA-induced arthritis in rats, International Journal of Polymeric Materials and Polymeric Biomaterials, 70, 12, 2021. Crossref

  2. Nkanga Christian Isalomboto, Fisch Andreas, Rad-Malekshahi Mazda, Romic Marieta Duvnjak, Kittel Birgit, Ullrich Thomas, Wang Jing, Krause Rui Werner Maçedo, Adler Sabine, Lammers Twan, Hennink Wim E., Ramazani Farshad, Clinically established biodegradable long acting injectables: An industry perspective, Advanced Drug Delivery Reviews, 167, 2020. Crossref

  3. Yang Guoyu, Wu Peng, Yu Cong, Zhang Jianxiang, Song Jinlin, Facile Engineering of Anti‐Inflammatory Nanotherapies by Host‐Guest Self‐Assembly, ChemistrySelect, 5, 28, 2020. Crossref

  4. Firozian Farzin, Emadi Mohammad Amin, Chehardoli Gholamabbas, Ghafari Fatemeh, Inulin Stearate Self-assembly Micro-rod Containing Paclitaxel: Synthesis and In Vitro Cytotoxicity MTT Assay in HeLa Cell Line, Journal of Pharmaceutical Innovation, 2021. Crossref

  5. Sousa-Batista Ariane de Jesus, Pacienza-Lima Wallace, Arruda-Costa Natalia, Falcão Camila Alves Bandeira, Ré Maria Ines, Rossi-Bergmann Bartira, Depot Subcutaneous Injection with Chalcone CH8-Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres as a Single-Dose Treatment of Cutaneous Leishmaniasis, Antimicrobial Agents and Chemotherapy, 62, 3, 2018. Crossref

  6. Barcia Emilia, Sandoval Virginia, Fernandez-Carballido Ana, Negro Sofía, Flunarizine-loaded microparticles for the prophylaxis of migraine, Journal of Drug Delivery Science and Technology, 60, 2020. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain